|
1
|
Xiong J, Xue FS, Yuan YJ, Wang Q, Liao X
and Wang WL: Cholinergic anti-inflammatory pathway: a possible
approach to protect against myocardial ischemia reperfusion injury.
Chin Med J (Engl). 123:2720–2726. 2010.PubMed/NCBI
|
|
2
|
Naidu BV, Farivar AS, Woolley SM, et al:
Novel broad-spectrum chemokine inhibitor protects against lung
ischemia-reperfusion injury. J Heart Lung Transplant. 23:128–134.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Renaud S and de Lorgeril M: Wine, alcohol,
platelets, and the French paradox for coronary heart disease.
Lancet. 339:1523–1526. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Athar M, Back JH, Tang X, et al:
Resveratrol: a review of preclinical studies for human cancer
prevention. Toxicol Appl Pharmacol. 224:274–283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aluyen JK, Ton QN, Tran T, et al:
Resveratrol: potential as anticancer agent. J Diet Suppl. 9:45–56.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Piotrowska H, Myszkowski K, Zio’łkowska A,
et al: Resveratrol analogue 3,4,4′,5-tetramethoxystilbene inhibits
growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3
and A-2780 cancer cells. Toxicol Appl Pharmacol. 263:53–60.
2012.
|
|
7
|
Afaq F, Adhami VM and Ahmad N: Prevention
of short-term ultraviolet B radiation-mediated damages by
resveratrol in SKH-1 hairless mice. Toxicol Appl Pharmacol.
186:28–37. 2003.PubMed/NCBI
|
|
8
|
Sehirli O, Sakarcan A, Velioğlu-Oğünç A,
et al: Resveratrol improves ifosfamide-induced Fanconi syndrome in
rats. Toxicol Appl Pharmacol. 222:33–41. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Y, Nie L, Yin YG, et al: Resveratrol
protects against hyperglycemia-induced oxidative damage to
mitochondria by activating SIRT1 in rat mesangial cells. Toxicol
Appl Pharmacol. 259:395–401. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li F, Gong Q, Dong H and Shi J:
Resveratrol, a neuroprotective supplement for Alzheimer’s disease.
Curr Pharm Des. 18:27–33. 2012.
|
|
11
|
López-Miranda V, Soto-Montenegro ML, Vera
G, et al: Resveratrol: a neuroprotective polyphenol in the
Mediterranean diet. Rev Neurol. 54:349–356. 2012.(In Spanish).
|
|
12
|
Lanzilli G, Cottarelli A, Nicotera G, et
al: Anti-inflammatory effect of resveratrol and polydatin by in
vitro IL-17 modulation. Inflammation. 35:240–248. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Black SC and Rodger IW: Methods for
studying experimental myocardial ischemic and reperfusion injury. J
Pharmacol Toxicol Methods. 35:179–190. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Speyer CL and Ward PA: Role of endothelial
chemokines and their receptors during inflammation. J Invest Surg.
24:18–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khimenko PL, Bagby GJ, Fuseler J and
Taylor AE: Tumor necrosis factor-alpha in ischemia and reperfusion
injury in rat lungs. J Appl Physiol (1985). 85:2005–2011.
1998.PubMed/NCBI
|
|
16
|
Batista ML Jr, Rosa JC, Lopes RD, et al:
Exercise training changes IL-10/TNF-alpha ratio in the skeletal
muscle of post-MI rats. Cytokine. 49:102–108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu J, Liu M, Kennedy RH and Liu SJ:
TNF-alpha-induced impairment of mitochondrial integrity and
apoptosis mediated by caspase-8 in adult ventricular myocytes.
Cytokine. 34:96–105. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meldrum DR, Cleveland JC Jr, Cain BS, Meng
X and Harken AH: Increased myocardial tumor necrosis factor-alpha
in a crystalloid-perfused model of cardiac ischemia-reperfusion
injury. Ann Thorac Surg. 65:439–443. 1998. View Article : Google Scholar
|
|
19
|
Gurevitch J, Frolkis I, Yuhas Y, et al:
Antitumor necrosis factor-alpha improves myocardial recovery after
ischemia and reperfusion. J Am Coll Cardiol. 30:1554–1561. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lefer AM, Ma XL, Weyrich A and Lefer DJ:
Endothelial dysfunction and neutrophil adherence as critical events
in the development of reperfusion injury. Agents Actions Suppl.
41:127–135. 1993.PubMed/NCBI
|
|
21
|
Schwartz BG and Kloner RA: Coronary no
reflow. J Mol Cell Cardiol. 52:873–882. 2012. View Article : Google Scholar
|
|
22
|
Ma XL, Lefer DJ, Lefer AM and Rothlein R:
Coronary endothelial and cardiac protective effects of a monoclonal
antibody to intercellular adhesion molecule-1 in myocardial
ischemia and reperfusion. Circulation. 86:937–946. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chandrasekar B, Smith JB and Freeman GL:
Ischemia-reperfusion of rat myocardium activates nuclear
factor-kappaB and induces neutrophil infiltration via
lipopolysaccharide-induced CXC chemokine. Circulation.
103:2296–2302. 2001. View Article : Google Scholar
|
|
24
|
Liu P, Hock CE, Nagele R and Wong PY:
Formation of nitric oxide, superoxide, and peroxynitrite in
myocardial ischemia-reperfusion injury in rats. Am J Physiol.
272:H2327–H2336. 1997.PubMed/NCBI
|
|
25
|
Li J, Wu F, Zhang H, et al: Insulin
inhibits leukocyte-endothelium adherence via an Akt-NO-dependent
mechanism in myocardial ischemia/reperfusion. J Mol Cell Cardiol.
47:512–519. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Zhang H, Wu F, et al: Insulin
inhibits tumor necrosis factor-alpha induction in myocardial
ischemia/reperfusion: role of Akt and endothelial nitric oxide
synthase phosphorylation. Crit Care Med. 36:1551–1558. 2008.
View Article : Google Scholar
|
|
27
|
Alcendor RR, Gao S, Zhai P, et al: Sirt1
regulates aging and resistance to oxidative stress in the heart.
Circ Res. 100:1512–1521. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Danz ED, Skramsted J, Henry N, Bennett JA
and Keller RS: Resveratrol prevents doxorubicin cardiotoxicity
through mitochondrial stabilization and the Sirt1 pathway. Free
Radic Biol Med. 46:1589–1597. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pillai JB, Isbatan A, Imai S and Gupta MP:
Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death
during heart failure is mediated by NAD+ depletion and
reduced Sir2alpha deacetylase activity. J Biol Chem.
280:43121–43130. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wallerath T, Li H, Godtel-Ambrust U,
Schwarz PM and Forstermann U: Blend of polyphenolic compounds
explains the stimulatory effect of red wine on human endothelial NO
synthase. Nitric Oxide. 12:97–104. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Penumathsa SV, Thirunavukkarasu M, Koneru
S, et al: Statin and resveratrol in combination induces
cardioprotection against myocardial infarction in
hypercholesterolemic rat. J Mol Cell Cardiol. 42:508–516. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rush JW, Quadrilatero J, Levy AS and Ford
RJ: Chronic resveratrol enhances endothelium-dependent relaxation
but does not alter eNOS levels in aorta of spontaneously
hypertensive rats. Exp Biol Med (Maywood). 232:814–822.
2007.PubMed/NCBI
|
|
33
|
Beher D, Wu J, Cumine S, et al:
Resveratrol is not a direct activator of SIRT1 enzyme activity.
Chem Biol Drug Des. 74:619–624. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chakrabarty SP, Balaram H and
Chandrasekaran S: Sirtuins: multifaceted drug targets. Curr Mol
Med. 11:709–718. 2011. View Article : Google Scholar : PubMed/NCBI
|
